These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6848127)

  • 41. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):967-76. PubMed ID: 3365373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acquired dysfibrinogenemia: monoclonal λ-type IgA binding to fibrinogen caused lower functional plasma fibrinogen level and abnormal clot formation.
    Arai S; Kamijo T; Takezawa Y; Sugano M; Nakazawa H; Yanagisawa R; Uehara T; Honda T; Okumura N
    Int J Hematol; 2020 Jul; 112(1):96-104. PubMed ID: 32253663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.
    Shainoff JR; Dardik BN
    J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of cryoprofibrin in fibrinogen-fibrin conversion.
    SHAINOFF JR; PAGE IH
    J Exp Med; 1962 Nov; 116(5):687-707. PubMed ID: 13988371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.
    Gralnick HR; Givelber H; Abrams E
    N Engl J Med; 1978 Aug; 299(5):221-6. PubMed ID: 207986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
    Southan C; Thompson E; Lane DA
    Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human factor XIa cleaves fibrinogen: effects on structure and function.
    Scott CF; Mentzer RL; Budzynski AZ; Colman RW
    Arch Biochem Biophys; 1986 Sep; 249(2):480-8. PubMed ID: 2944482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gamma globulin inhibition of fibrin clot formation.
    Davey FR; Gordon GB; Boral LI; Gottlieb AJ
    Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional and metabolic properties of human asialofibrinogen.
    Martinez J; Palascak J; Peters C
    J Lab Clin Med; 1977 Feb; 89(2):367-77. PubMed ID: 833473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble fibrin consists of fibrin oligomers of heterogeneous distribution.
    Rötker J; Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 Mar; 155(3):583-8. PubMed ID: 3956500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrin formation: the role of the fibrinogen-fibrin monomer complex.
    Brass EP; Forman WB; Edwards RV; Lindan O
    Thromb Haemost; 1976 Aug; 36(1):37-48. PubMed ID: 1036827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.